Sysmex Europe
Sysmex Europe
Other Sites
Menu

March - Anti-platelet drugs mechanism

Blood platelets are activated by collagen released at the site of a vascular injury, by the change of blood flow (shear stress) and by thrombin formation. Platelets also increase their own activation by two mechanisms: the release of ADP and the thromboxane A2generation (TXA2), a potent platelet agonist. These mechanisms are also anti-platelet drugs’ main pharmacological targets: ADP receptor antagonists (thienopyridines) blockplatelet ADP receptors (P2Y12). Aspirin blocks cyclooxygenase (COX1), responsible for generating thromboxane A2 (TXA2). Sysmex’s CS-series coagulation analysers (exceptCS-1600) monitor anti-platelet drugs by Revohem reagents (ADP, arachidonic acid).

Haemostasis

Scientific Calendar 2017

Growing your knowledge
Visit our Academy
Enjoy our Media Centre
All
  • All
  • Documents
  • Podcast
  • Images
  • Videos
See our collection
Find your job